How long after stopping Wegovy will you feel better?

What published trial data tells us about how the body responds

The STEP 1 withdrawal extension is the clearest evidence we have. Participants who stopped semaglutide 2.4mg after 68 weeks regained, on average, two-thirds of the weight they had lost within the following year. That finding, published in the New England Journal of Medicine, tells us something important: the medicine was doing a lot of the metabolic heavy lifting. Once it leaves your system, hunger signalling and appetite return toward their pre-treatment baseline. For most people that process begins within two to three weeks of the last injection, and is largely complete by six to eight weeks. The GI symptoms that many people find difficult on treatment (nausea, reflux, loose stools) tend to resolve earlier, often within the first week or two. Energy levels and general wellbeing usually follow soon after. If you were tolerating Wegovy well and felt good on it, "feeling better" after stopping may not be straightforward; some people feel distinctly worse once appetite surges back. That is physiology, not failure. Understanding how long semaglutide stays in your system after stopping helps set realistic expectations for this window.

The side-effect resolution timeline, week by week

A question our prescribers hear most weeks is whether the nausea and fatigue will lift quickly once someone stops. The short answer is yes, and faster than people expect. Because each dose of Wegovy adds to the previous week's residual level, the reverse is also true: as that reservoir depletes, effects diminish progressively rather than all at once. By day seven after the last injection, roughly half the active drug has gone. By day 14, about three-quarters. By week five, clearance is effectively complete for most people. Practically, this means GI discomfort is usually the first thing to improve, frequently within three to seven days. Fatigue and headache resolve close behind. What persists longer (sometimes several weeks) is the slower return of full appetite and any changes to bowel habit that had settled during treatment. If you are stopping because of a specific side effect rather than because treatment is complete, it is worth reading the NHS semaglutide patient guidance for a clear account of which effects are typically short-lived and which warrant a call to your prescriber. You can also explore our overview of how long Wegovy takes to feel different for context on what the treatment period itself involves.

Weight and appetite after stopping: what to expect

The return of appetite is the most clinically significant change after stopping, and it can feel abrupt. GLP-1 receptor agonists slow gastric emptying and reduce hunger signals; without that brake, many people find they feel hungrier than they did before they started treatment, not just back to baseline. Trial data confirms this: appetite and food cravings typically exceed pre-treatment levels in the early weeks after stopping, which is part of why weight regain happens so quickly in the evidence. The practical question of whether weight lost on Wegovy stays off depends heavily on what habits were built during treatment. Protein adequacy, regular meals and some resistance activity during the treatment period give the body the best structural foundation when the medicine is no longer there. How quickly the number on the scale moves after stopping varies, but most people see some regain within weeks, with the steepest trajectory in the first three months. This is not unique to Wegovy. It reflects a broader truth about obesity as a chronic condition shaped by biology, not a short-term fix resolved by a course of treatment. For those considering how long they might stay on treatment in the first place, our page on how long people typically remain on Wegovy covers NICE's two-year recommendation and the clinical thinking behind it.

When to speak to a prescriber before or after stopping

Stopping a GLP-1 medicine is not dangerous in the way stopping some medicines (such as steroids or antidepressants) can be — there is no withdrawal syndrome to manage. But it is still a clinical decision, not an administrative one. If you are stopping because of side effects, a prescriber can often help: dose adjustments, slower titration or a temporary pause can sometimes resolve problems that prompted a full stop. If you are stopping because treatment feels complete, a clear handover plan (dietary structure, activity targets, follow-up) makes a significant difference to long-term outcomes. The MHRA advises reporting any suspected side effects, including ones that arise after stopping, via the Yellow Card scheme. If you are thinking about restarting, or wondering whether Wegovy is the right fit for you in the first place, the full Wegovy overview covers eligibility, what treatment involves and what the evidence says about results. For a broader look at all licensed weight-loss treatment options, our treatment options page sets out the landscape plainly. Speak to our prescribers if you have questions about stopping, pausing or restarting, they review every case individually, the same day.